Goldman Sachs leads a $4.25 billion financing package to support Sycamore Partners' $12.5 billion acquisition of Walgreens Boots Alliance's UK pharmacy chain.

Target Information

Sycamore Partners is set to acquire Walgreens Boots Alliance's UK-based pharmacy chain for $12.5 billion. This acquisition is part of a broader strategy to enhance Sycamore’s presence in the consumer healthcare sector, capitalizing on the growing demand for pharmacy services in the UK.

Walgreens Boots Alliance has a well-established network of pharmacies and healthcare services in the UK, which positions it as a key player in the market. The deal aligns with the trends in healthcare where accessibility and convenience are becoming increasingly vital for consumers.

Industry Overview

The UK's pharmacy market has shown resilience and growth potential despite recent economic challenges. With a significant shift towards health and wellness, consumers

View Source

Similar Deals

PHL Group Totally Plc

2025

Buyout Hospitals, Clinics & Primary Care Services United Kingdom
Consensus Creative Care

2025

Buyout Residential & Long-Term Care United Kingdom
Bridgepoint Advisers Limited mydentist

2025

Buyout Hospitals, Clinics & Primary Care Services United Kingdom
Investindustrial DCC Healthcare

2025

Buyout Healthcare Facilities & Services (NEC) United Kingdom
MMS Exploristics

2025

Buyout Biotechnology & Medical Research (NEC) United Kingdom
Beacon Homecare Services Limited Lifetime Homecare Limited

2025

Buyout Home Healthcare Services United Kingdom

Sycamore Partners

invested in

Walgreens Boots Alliance’s UK-based pharmacy chain

in 2025

in a Buyout deal

Disclosed details

Transaction Size: $12,500M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert